SNEX vs. ABBV
SNEX (StoneX Group Inc.) and ABBV (AbbVie Inc.) are both stocks. SNEX operates in Capital Markets (Financial Services), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SNEX returned 32.52%/yr vs 19.10%/yr for ABBV. At a 0.21 correlation, their price movements are largely independent.
Performance
SNEX vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SNEX achieves a 106.07% return, which is significantly higher than ABBV's 1.30% return. Over the past 10 years, SNEX has outperformed ABBV with an annualized return of 32.52%, while ABBV has yielded a comparatively lower 19.10% annualized return.
SNEX
- 1D
- 0.73%
- 1M
- 18.58%
- YTD
- 106.07%
- 6M
- 101.21%
- 1Y
- 132.71%
- 3Y*
- 70.28%
- 5Y*
- 45.86%
- 10Y*
- 32.52%
ABBV
- 1D
- 1.32%
- 1M
- 8.24%
- YTD
- 1.30%
- 6M
- 3.65%
- 1Y
- 23.06%
- 3Y*
- 22.39%
- 5Y*
- 18.94%
- 10Y*
- 19.10%
SNEX vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SNEX StoneX Group Inc. | 106.07% | 45.65% | 32.70% | 16.21% | 55.59% | 5.79% | 18.57% | 33.49% | -13.99% | 7.40% |
ABBV AbbVie Inc. | 1.30% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between SNEX and ABBV is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.21 |
The correlation between SNEX and ABBV shifts across timeframes, from 0.08 (1 year) to 0.21 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
SNEX:
$10.65B
ABBV:
$403.99B
SNEX:
$7.78
ABBV:
$2.05
SNEX:
16.79
ABBV:
110.96
SNEX:
0.05
ABBV:
6.43
SNEX:
3.94
ABBV:
14.69
SNEX:
$152.34B
ABBV:
$62.82B
SNEX:
$47.64B
ABBV:
$46.15B
SNEX:
$2.46B
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SNEX vs. ABBV — Risk / Return Rank
SNEX
ABBV
SNEX vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for StoneX Group Inc. (SNEX) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SNEX | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.17 | ||
| Sortino ratioReturn per unit of downside risk | +1.85 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.18 | +0.31 |
| Calmar ratioReturn relative to maximum drawdown | 6.26 | 1.29 | +4.97 |
| Martin ratioReturn relative to average drawdown | 16.05 | 2.88 | +13.17 |
Loading charts...
Drawdowns
SNEX vs. ABBV - Drawdown Comparison
The maximum SNEX drawdown since its inception was -97.89%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for SNEX and ABBV.
Loading charts...
Drawdown Indicators
| SNEX | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.89% | -45.09% | -52.80% |
Max Drawdown (1Y)Largest decline over 1 year | -20.91% | -17.32% | -3.59% |
Max Drawdown (3Y)Largest decline over 3 years | -20.91% | -20.74% | -0.17% |
Max Drawdown (5Y)Largest decline over 5 years | -24.07% | -21.92% | -2.15% |
Max Drawdown (10Y)Largest decline over 10 years | -48.65% | -45.09% | -3.56% |
Current DrawdownCurrent decline from peak | 0.00% | -4.60% | +4.60% |
Average DrawdownAverage peak-to-trough decline | -42.89% | -10.71% | -32.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.15% | 7.75% | +0.40% |
Volatility
SNEX vs. ABBV - Volatility Comparison
StoneX Group Inc. (SNEX) has a higher volatility of 12.49% compared to AbbVie Inc. (ABBV) at 6.10%. This indicates that SNEX's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SNEX | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.49% | 6.10% | +6.39% |
Volatility (6M)Calculated over the trailing 6-month period | 30.78% | 17.85% | +12.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.37% | 24.31% | +18.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.13% | 22.89% | +12.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.47% | 25.73% | +10.74% |
Dividends
SNEX vs. ABBV - Dividend Comparison
SNEX has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 2.96%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.96% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
SNEX StoneX Group Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SNEX vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between StoneX Group Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SNEX vs. ABBV - Profitability Comparison
SNEX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, StoneX Group Inc. reported a gross profit of 45.35B and revenue of 45.76B. Therefore, the gross margin over that period was 99.1%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
SNEX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, StoneX Group Inc. reported an operating income of 45.32B and revenue of 45.76B, resulting in an operating margin of 99.0%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
SNEX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, StoneX Group Inc. reported a net income of 174.30M and revenue of 45.76B, resulting in a net margin of 0.4%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
Frequently Asked Questions
SNEX and ABBV have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SNEX has higher volatility (12.49%) compared to ABBV (6.10%). In terms of maximum drawdown, SNEX dropped -97.89% vs ABBV's -45.09%.
SNEX currently has the higher Sharpe Ratio (3.09 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SNEX and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer